Japan Multiomics Market Size & Outlook, 2023-2030
Japan multiomics market, 2018-2030 (US$M)
Related Markets
Japan multiomics market highlights
- The Japan multiomics market generated a revenue of USD 79.1 million in 2023 and is expected to reach USD 237.7 million by 2030.
- The Japan market is expected to grow at a CAGR of 17% from 2024 to 2030.
- In terms of segment, product was the largest revenue generating product & service in 2023.
- Services is the most lucrative product & service segment registering the fastest growth during the forecast period.
Multiomics market data book summary
| Market revenue in 2023 | USD 79.1 million |
| Market revenue in 2030 | USD 237.7 million |
| Growth rate | 17% (CAGR from 2023 to 2030) |
| Largest segment | Product |
| Fastest growing segment | Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Services, Product |
| Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Danaher Corp, Shimadzu Corp, Bruker Corp, Qiagen NV, Agilent Technologies Inc, BD, Revvity Inc, BGI Group |
Other key industry trends
- In terms of revenue, Japan accounted for 3.4% of the global multiomics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China multiomics market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 194.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Multiomics Market Scope
Multiomics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan multiomics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to multiomics market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 56.89% in 2023. Horizon Databook has segmented the Japan multiomics market based on services, product covering the revenue growth of each sub-segment from 2018 to 2030.
Healthcare and clinical research service providers in Japan have been progressively incorporating sequencing technologies over the past few years and are projected to play a significant role in the Asia Pacific genomics revenue share.
For instance, in April 2022, the Okinawa Institute of Science and Technology Graduate University (OIST), in collaboration with Tokyo-based Corundum Systems Biology Inc., introduced a research project aimed at developing a complete automated system for disease prediction by fiscal year 2024.
Furthermore, numerous hospitals in Japan have initiated the use of Next-Generation Sequencing (NGS)- based mutational profile screening for patients diagnosed with solid tumors, aiding in guiding patients toward appropriate clinical trials. The Ministry of Health, Labour and Welfare of Japan has also approved various cancer gene panels to be employed in clinical practice.
Reasons to subscribe to Japan multiomics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Japan multiomics market databook
-
Our clientele includes a mix of multiomics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan multiomics market , including forecasts for subscribers. This country databook contains high-level insights into Japan multiomics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Japan multiomics market size, by product & service, 2018-2030 (US$M)
Japan Multiomics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
